MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis

Varun Nagpal, Rahul Rai, Aaron T. Place, Sheila B. Murphy, Suresh K. Verma, Asish K Ghosh, Douglas E Vaughan*

*Corresponding author for this work

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Cardiac fibrosis is the pathological consequence of stress-induced fibroblast proliferation and fibroblast-to-myofibroblast transition. MicroRNAs have been shown to play a central role in the pathogenesis of cardiac fibrosis. We identified a novel miRNA-driven mechanism that promotes cardiac fibrosis via regulation of multiple fibrogenic pathways. Methods and Results-Using a combination of in vitro and in vivo studies, we identified that miR-125b is a novel regulator of cardiac fibrosis, proliferation, and activation of cardiac fibroblasts. We demonstrate that miR-125b is induced in both fibrotic human heart and murine models of cardiac fibrosis. In addition, our results indicate that miR-125b is necessary and sufficient for the induction of fibroblast-to-myofibroblast transition by functionally targeting apelin, a critical repressor of fibrogenesis. Furthermore, we observed that miR-125b inhibits p53 to induce fibroblast proliferation. Most importantly, in vivo silencing of miR-125b by systemic delivery of locked nucleic acid rescued angiotensin II-induced perivascular and interstitial fibrosis. Finally, the RNA-sequencing analysis established that miR-125b altered the gene expression profiles of the key fibrosis-related genes and is a core component of fibrogenesis in the heart. Conclusions-In conclusion, miR-125b is critical for induction of cardiac fibrosis and acts as a potent repressor of multiple anti-fibrotic mechanisms. Inhibition of miR-125b may represent a novel therapeutic approach for the treatment of human cardiac fibrosis and other fibrotic diseases.

Original languageEnglish (US)
Pages (from-to)291-301
Number of pages11
JournalCirculation
Volume133
Issue number3
DOIs
StatePublished - Jan 19 2016

Fingerprint

Myofibroblasts
Fibrosis
Fibroblasts
MicroRNAs
RNA Sequence Analysis
Transcriptome
Angiotensin II

Keywords

  • Angiotensin II
  • RNA sequence
  • fibrosis
  • miR-125b
  • transforming growth factor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Nagpal, Varun ; Rai, Rahul ; Place, Aaron T. ; Murphy, Sheila B. ; Verma, Suresh K. ; Ghosh, Asish K ; Vaughan, Douglas E. / MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis. In: Circulation. 2016 ; Vol. 133, No. 3. pp. 291-301.
@article{ee88da002e844f85ac377bb28eede751,
title = "MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis",
abstract = "Cardiac fibrosis is the pathological consequence of stress-induced fibroblast proliferation and fibroblast-to-myofibroblast transition. MicroRNAs have been shown to play a central role in the pathogenesis of cardiac fibrosis. We identified a novel miRNA-driven mechanism that promotes cardiac fibrosis via regulation of multiple fibrogenic pathways. Methods and Results-Using a combination of in vitro and in vivo studies, we identified that miR-125b is a novel regulator of cardiac fibrosis, proliferation, and activation of cardiac fibroblasts. We demonstrate that miR-125b is induced in both fibrotic human heart and murine models of cardiac fibrosis. In addition, our results indicate that miR-125b is necessary and sufficient for the induction of fibroblast-to-myofibroblast transition by functionally targeting apelin, a critical repressor of fibrogenesis. Furthermore, we observed that miR-125b inhibits p53 to induce fibroblast proliferation. Most importantly, in vivo silencing of miR-125b by systemic delivery of locked nucleic acid rescued angiotensin II-induced perivascular and interstitial fibrosis. Finally, the RNA-sequencing analysis established that miR-125b altered the gene expression profiles of the key fibrosis-related genes and is a core component of fibrogenesis in the heart. Conclusions-In conclusion, miR-125b is critical for induction of cardiac fibrosis and acts as a potent repressor of multiple anti-fibrotic mechanisms. Inhibition of miR-125b may represent a novel therapeutic approach for the treatment of human cardiac fibrosis and other fibrotic diseases.",
keywords = "Angiotensin II, RNA sequence, fibrosis, miR-125b, transforming growth factor",
author = "Varun Nagpal and Rahul Rai and Place, {Aaron T.} and Murphy, {Sheila B.} and Verma, {Suresh K.} and Ghosh, {Asish K} and Vaughan, {Douglas E}",
year = "2016",
month = "1",
day = "19",
doi = "10.1161/CIRCULATIONAHA.115.018174",
language = "English (US)",
volume = "133",
pages = "291--301",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis. / Nagpal, Varun; Rai, Rahul; Place, Aaron T.; Murphy, Sheila B.; Verma, Suresh K.; Ghosh, Asish K; Vaughan, Douglas E.

In: Circulation, Vol. 133, No. 3, 19.01.2016, p. 291-301.

Research output: Contribution to journalArticle

TY - JOUR

T1 - MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis

AU - Nagpal, Varun

AU - Rai, Rahul

AU - Place, Aaron T.

AU - Murphy, Sheila B.

AU - Verma, Suresh K.

AU - Ghosh, Asish K

AU - Vaughan, Douglas E

PY - 2016/1/19

Y1 - 2016/1/19

N2 - Cardiac fibrosis is the pathological consequence of stress-induced fibroblast proliferation and fibroblast-to-myofibroblast transition. MicroRNAs have been shown to play a central role in the pathogenesis of cardiac fibrosis. We identified a novel miRNA-driven mechanism that promotes cardiac fibrosis via regulation of multiple fibrogenic pathways. Methods and Results-Using a combination of in vitro and in vivo studies, we identified that miR-125b is a novel regulator of cardiac fibrosis, proliferation, and activation of cardiac fibroblasts. We demonstrate that miR-125b is induced in both fibrotic human heart and murine models of cardiac fibrosis. In addition, our results indicate that miR-125b is necessary and sufficient for the induction of fibroblast-to-myofibroblast transition by functionally targeting apelin, a critical repressor of fibrogenesis. Furthermore, we observed that miR-125b inhibits p53 to induce fibroblast proliferation. Most importantly, in vivo silencing of miR-125b by systemic delivery of locked nucleic acid rescued angiotensin II-induced perivascular and interstitial fibrosis. Finally, the RNA-sequencing analysis established that miR-125b altered the gene expression profiles of the key fibrosis-related genes and is a core component of fibrogenesis in the heart. Conclusions-In conclusion, miR-125b is critical for induction of cardiac fibrosis and acts as a potent repressor of multiple anti-fibrotic mechanisms. Inhibition of miR-125b may represent a novel therapeutic approach for the treatment of human cardiac fibrosis and other fibrotic diseases.

AB - Cardiac fibrosis is the pathological consequence of stress-induced fibroblast proliferation and fibroblast-to-myofibroblast transition. MicroRNAs have been shown to play a central role in the pathogenesis of cardiac fibrosis. We identified a novel miRNA-driven mechanism that promotes cardiac fibrosis via regulation of multiple fibrogenic pathways. Methods and Results-Using a combination of in vitro and in vivo studies, we identified that miR-125b is a novel regulator of cardiac fibrosis, proliferation, and activation of cardiac fibroblasts. We demonstrate that miR-125b is induced in both fibrotic human heart and murine models of cardiac fibrosis. In addition, our results indicate that miR-125b is necessary and sufficient for the induction of fibroblast-to-myofibroblast transition by functionally targeting apelin, a critical repressor of fibrogenesis. Furthermore, we observed that miR-125b inhibits p53 to induce fibroblast proliferation. Most importantly, in vivo silencing of miR-125b by systemic delivery of locked nucleic acid rescued angiotensin II-induced perivascular and interstitial fibrosis. Finally, the RNA-sequencing analysis established that miR-125b altered the gene expression profiles of the key fibrosis-related genes and is a core component of fibrogenesis in the heart. Conclusions-In conclusion, miR-125b is critical for induction of cardiac fibrosis and acts as a potent repressor of multiple anti-fibrotic mechanisms. Inhibition of miR-125b may represent a novel therapeutic approach for the treatment of human cardiac fibrosis and other fibrotic diseases.

KW - Angiotensin II

KW - RNA sequence

KW - fibrosis

KW - miR-125b

KW - transforming growth factor

UR - http://www.scopus.com/inward/record.url?scp=84955693617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955693617&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.115.018174

DO - 10.1161/CIRCULATIONAHA.115.018174

M3 - Article

VL - 133

SP - 291

EP - 301

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 3

ER -